Back
Adaptive Biotechnologies Corp. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
62
ADPT
Adaptive Biotechnologies Corp.
Last Price:
$17.46
Seasonality Move:
-8.01%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAdaptive Biotechnologies Corp. Stock Forecast
-
Over the next 52 weeks, Adaptive Biotechnologies Corp. has on average historically risen by 19.8% based on the past 6 years of stock performance.
-
Adaptive Biotechnologies Corp. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Adaptive Biotechnologies Corp. Stock Undervalued?The current Adaptive Biotechnologies Corp. [ADPT] share price is $17.46. The Score for ADPT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ADPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Adaptive Biotechnologies Corp. Stock Go Up Next Year?
-
Over the next 52 weeks, Adaptive Biotechnologies Corp. has on average historically risen by 19.8% based on the past 6 years of stock performance.
Adaptive Biotechnologies Corp. Stock Rating
Buy
62
Adaptive Biotechnologies Corp. (ADPT)
is a Buy
Is Adaptive Biotechnologies Corp. overpriced?
-
Adaptive Biotechnologies Corp. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Adaptive Biotechnologies Corp. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
adaptivebiotech.com
52-Week Data
52-Week High:
20.76
52-Week Low:
5.81
Prediction Charts
Market Cap:
2.7B
Price in USD:
17.46
Volume:
2.9M
Beta:
1.51
Technical Analysis
SMA50:
16.20
SMA100:
14.19
SMA200:
11.60
52-Wk Change:
184.36%
Stock Predictions
-
Is Adaptive Biotechnologies Corp. stock public?Yes, Adaptive Biotechnologies Corp. is a publicly traded company.
-
What is the Adaptive Biotechnologies Corp. stock quote today?The Adaptive Biotechnologies Corp. stock price is 17.46 USD today.
-
How to buy Adaptive Biotechnologies Corp. stock online?You can buy Adaptive Biotechnologies Corp. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 13.71 | 14.10 | 14.21 | 13.45 |
| Nov-17 | 14.00 | 13.71 | 14.24 | 13.65 |
| Nov-18 | 13.53 | 13.75 | 13.95 | 13.28 |
| Nov-19 | 13.85 | 15.15 | 15.38 | 13.73 |
| Nov-20 | 15.58 | 16.32 | 16.97 | 15.58 |
| Nov-21 | 16.28 | 18.61 | 18.98 | 16.18 |
| Nov-24 | 18.95 | 20.46 | 20.65 | 18.40 |
| Nov-25 | 20.36 | 20.32 | 20.76 | 19.60 |
| Nov-26 | 20.23 | 19.72 | 20.34 | 19.40 |
| Nov-28 | 19.72 | 19.66 | 19.72 | 19.25 |
| Dec-1 | 19.26 | 18.84 | 19.31 | 18.59 |
| Dec-2 | 18.84 | 18.69 | 19.27 | 18.52 |
| Dec-3 | 18.87 | 17.13 | 18.87 | 16.50 |
| Dec-4 | 16.86 | 17.46 | 17.58 | 16.45 |
Adaptive Biotechnologies Corp. Earnings
Adaptive Biotechnologies Corp. Earnings Report: Per Share Adaptive Biotechnologies Corp. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Adaptive Biotechnologies Corp. Forecast Revenue Growth
Adaptive Biotechnologies Corp. Stock Analysis: Historical quarterly revenues per share for Adaptive Biotechnologies Corp. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and a decrease next year of $0.09 per share.
* Adaptive Biotechnologies Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.